Sensory axons, but not soma, from Type III Nrg1^+/− mice show reduced capsaicin responsiveness compared to axons from WT mice.

<p>(A) Representative traces of intracellular calcium along sensory axons in response to 1 µM capsaicin or 56 mM KCl. The change in intracellular calcium from baseline over time ([(F−F₀)/F₀]*100) is shown for WT (left) and Type III Nrg1^+/− (right) axons. Hatched diagonal lines indicate where the time course was non-continuous. (B) Quantification of the maximum change in intracellular calcium in response to application of 1 µM capsaicin or 56 mM KCl by genotype. Averages of 5 animals per genotype were compared using a Student's t-test. Type III Nrg1^+/− axons showed a significantly decreased response to capsaicin (p<0.05), but not to KCl, relative to WTs. Graph shows mean±SEM. (C) Type III Nrg1^+/− sensory soma show normal response to capsaicin. Quantification of maximal change in fluorescence from baseline ([(F−F₀)/F₀]*100) in WT or Type III Nrg1^+/− sensory neuron <i>soma</i> in response to 1 µM capsaicin or 56 mM KCl. Average responses from 4 WT and 4 Type III Nrg1^+/− animals to application of capsaicin or KCl were compared by genotype using a Student's t-test. There was no statistically significant difference between genotypes. Graphs show mean±SEM. (D) Type III Nrg1 (green) and TRPV1 (red) are co-expressed along P21 WT cultured sensory neuron axons identified with a pan-axonal (PA) marker (blue). White arrows indicate examples where Type III Nrg1 and TRPV1 are in close proximity. Scale bar equals 10 µm. (E) P21 WT and Type III Nrg1^+/− sensory neuron cultures have equivalent levels of total TRPV1 protein. Total TRPV1 protein measurement by immunoblot. The 95 kD TRPV1 band and the 35 kD GAPDH band are shown from a representative experiment comparing protein from P21 WT and Type III Nrg1^+/− cultures. Quantification of fold change in intensity of TRPV1∶GAPDH normalized to WT average. There was no statistically significant change in the ratio of TRPV1 to GAPDH between genotypes (WT, Type III Nrg1^+/−, n = 3 animals). Genotype comparisons were made using a Student's t-test. Graph shows mean±SEM.</p

Type III Nrg1^+/− sensory axons have reduced numbers of Nrg1⁺ punctae that contain a signaling-competent intracellular domain (Nrg1-ICD) relative to WT sensory axons.

<p>(A) Conventional microscopic images of Nrg1-ICD⁺ punctae (green) found along peripherin⁺ axons (blue) from WT and Type III Nrg1^+/− sensory cultures. Scale bars equal 10 µm. (B) Quantification of the average number of punctae per 100 µm axon length from 14 WT and 15 Type III Nrg1^+/− images. Comparison by genotype illustrates that Type III Nrg1^+/− sensory axons have significantly fewer Nrg1-ICD⁺ punctae than WT sensory axons (Mann-Whitney Rank Sum test, ***p<0.001).</p

sErbB4-ECD stimulation of Type III Nrg1^+/− sensory neuron cultures fails to activate PtdIns3K along sensory axons.

<p>(A) Representative images of pAKT staining along WT and Type III Nrg1^+/− sensory axons stimulated for 15 minutes with either control or sErbB4-ECD media. All scale bars equal 10 µm. (B) Quantification of pAKT average fluorescence intensity (AFI) along WT and Type III Nrg1^+/− sensory axons under various treatment conditions. sErbB4-ECD stimulation significantly increased AFI levels for pAKT staining along P21 WT sensory axons (WT CON, n = 3 animals; WT B4, n = 3; *p<0.05) but not along sensory axons from Type III Nrg1^+/− cultures (Type III Nrg1^+/− CON, n = 3 animals; Type III Nrg1^+/− B4, n = 3; p = 0.9). All comparisons between treatments and genotypes were made using an ANOVA with a Fischer's PLSD post-hoc analysis. Graph shows mean±SEM.</p

Type III Nrg1^+/− sensory axons have reduced numbers of Type III Nrg1⁺ punctae relative to WT sensory axons.

<p>(A) Conventional microscopic images of Type III Nrg1⁺ punctae (green) found along peripherin⁺ axons (blue) from WT and Type III Nrg1^+/− sensory cultures. Scale bars equal 10 µm. (B) Quantification of the average number of punctae per 100 µm axon length from 16 WT and 15 Type III Nrg1^+/− images. Comparison by genotype illustrates that Type III Nrg1^+/− sensory axons have significantly fewer Type III Nrg1⁺ punctae than WT sensory axons (Mann-Whitney Rank Sum test, *p<0.05).</p

Stimulation of Type III Nrg1 signaling enhances response to capsaicin in WT sensory axons.

<p>(A) Representative traces of intracellular calcium along WT sensory axons in response to repeated applications of 1 µM capsaicin followed by application of 56 mM KCl. The maximum percent change in intracellular calcium ([(F−F₀)/F₀]*100) in response to capsaicin decreased between the 4^th and 5^th capsaicin applications under control conditions (left), but increased when Type III Nrg1 signaling was stimulated by sErbB4-ECD application during that interval (right). (B) Quantification of percent change in maximum response to capsaicin between the 4^th and the 5^th capsaicin application ([(F₅−F₄)/F₄]*100) by treatment. WT sensory axons showed a significantly enhanced response to capsaicin when Type III Nrg1 signaling was stimulated with sErbB4-ECD (WT CON, n = 10 animals; WT B4, n = 7 animals; Student's t-test, ***p<0.001). Graph shows mean±SEM.</p

Acute stimulation of Type III Nrg1 signaling in Type III Nrg1^+/− sensory axons does not rescue functional TRPV1 deficits.

<p>(A) Representative traces of intracellular calcium along Type III Nrg1^+/− sensory axons in response to repeated applications of 1 µM capsaicin followed by application of 56 mM KCl. The maximum percent change in intracellular calcium ([(F−F₀)/F₀]*100) in response to capsaicin decreased between the 4^th and 5^th capsaicin application in Type III Nrg1^+/− axons under control conditions (left) and did not increase when Type III Nrg1 signaling was stimulated by sErbB4-ECD application during that interval (right). (B) Quantification of percent change in maximum response to capsaicin between the 4^th and the 5^th capsaicin application ([(F₅−F₄)/F₄]*100) by treatment. Results from WT sensory axons are included for comparison (WT CON, n = 10; WT B4, n = 7; ***p<0.001). Type III Nrg1^+/− axons did not show a statistically significantly enhanced response to capsaicin when Type III Nrg1 signaling was stimulated (Type III Nrg1^+/− CON, n = 6 animals; Type III Nrg1^+/− B4, n = 8). All comparisons between genotypes and treatments were made using an ANOVA with a Holm-Sidak post-hoc test for multiple comparisons. Graph shows mean±SEM.</p

Pre-treatment with sErbB4-ECD enhances response to a second application of capsaicin along sensory axons.

<p>(A) Sensory neuron cultures from P21 WT mice were incubated with sErbB4-ECD or control media for 12 minutes before two 1 µM pulses of capsaicin were applied (spaced 4 minutes apart), followed by application of 56 mM KCl. Within axons that responded to both capsaicin and KCl, the percent change in fluorescence from baseline ([(F−F₀)/F₀]*100) in response to both applications of capsaicin as well as KCl was calculated. Axonal responses were averaged by animal and normalized to the WT CON average. (B–C) Quantification of the maximum response to the first (B) or second (C) applications of 1 µM capsaicin were compared by treatment. Pre-treatment with sErbB4-ECD significantly increased the maximum response to the second pulse of capsaicin (WT CON, n = 8 animals; WT B4, n = 9 animals; *p<0.05). There was a trend towards an increase in response to the first pulse of capsaicin following sErbB4-ECD pre-treatment (p = 0.17). (D) Quantification of the maximum response to KCl by treatment. sErbB4-ECD pre-treatment had no effect on the maximum response to KCl (p = 0.38). (E) The percent change between the maximum response to the first and second capsaicin applications was calculated and axonal values were averaged by animal. Quantification of this percent change in response by treatment; Cultures pre-treated with sErbB4-ECD showed significantly less of a decrease in responsiveness to capsaicin between the first and second capsaicin applications (*p<0.05). All treatment comparisons were made using a Student's t-test. Graphs show mean±SEM.</p

Adult WT and Type III Nrg1^+/− animals have equivalent numbers of sensory neurons and sensory cutaneous projections.

<p>(A) Representative sections through L4/L5 DRG from adult WT and Type III Nrg1^+/− mice were stained with a pan-sensory marker. Total cells staining positive for this marker tallied from at least 5 sections evenly spaced throughout the DRG were counted and averaged for each animal. Genotype averages were compared with a Student's t-test (n = 3 animals per genotype). There was no statistically significant difference between genotypes. (B) Galabrous hindpaw skin samples from WT and Type III Nrg1^+/− mice were assessed for total TrkA, Ret and TRPV1 protein using immunoblot. (C) The intensity of the TrkA, Ret and TRPV1 bands were quantified and normalized to GAPDH to control for equal protein loading. The values were expressed as a fold change from the average WT value and genotype averages were compared with a Student's t-test (for TrkA and Ret: WT n = 13 paws from 10 animals, Type III Nrg1^+/− n = 13 paws from 9 animals; for TRPV1: WT n = 9 paws from 5 animals, Type III Nrg1^+/− n = 8 paws from 5 animals). There was no statistically significant difference between the genotypes.</p

PtdIns3K activation is required for Type III Nrg1-induced enhancement of capsaicin responsiveness.

<p>(A) 15-minute stimulation of Type III Nrg1 signaling with sErbB4-ECD significantly increased the ratio of pAKT-AKT in whole cell lysates from P21 WT sensory neuron cultures (a: CON, n = 3; B4, n = 4; Student's t-test, *p<0.05). This increase was blocked by pre-incubation with 20 nM wortmannin (WM), an inhibitor of PtdIns3K activity. (b) The same stimulation of Type III Nrg1 with sErbB4-ECD did not activate the MAPK pathway as illustrated by the lack of effect on the ratio of pERK-ERK. (B) Stimulation of Type III Nrg1 signaling with sErbB4-ECD significantly increased average fluorescence intensity (AFI) levels for pAKT staining along P21 WT cultured sensory axons (15 minutes; CON, n = 3; B4, n = 3; Student's t-test, *p<0.05). Scale bars equal 10 µm. (C) Blocking PtdIns3K signaling with 50 µM LY294002 or 20 nM wortmannin blocked the Type III Nrg1-induced enhancement of functional TRPV1 (LY CON, n = 3 animals; LY B4, n = 2; WM CON, n = 10; WM B4, n = 7). Comparisons between CON and all treatment groups were made using an ANOVA with a Holm-Sidak post-hoc test for multiple comparisons. All graphs show mean±SEM.</p

Type III Nrg1 expression in adult nociceptive sensory neuron soma and peripheral nerve terminals in vivo.

<p>(A) Type III Nrg1 (b,e,h) is found in nociceptive TrkA+ (a–c) and IB4+ (d–f), as well as TRPV1+ (g–i) sensory neuron soma in lumbar dorsal root ganglia. (B) Type III Nrg1 (b′,e′) is found in nociceptive peripheral nerve terminals innervating the plantar hindpaw skin as marked with an antibody against CGRP (a′) as well as TRPV1 (d′). White arrows indicate examples of soma or nerve terminals that are expressing both Type III Nrg1 and the particular sensory marker. All scale bars equal 10 µm.</p